We’ve done it again! Our newest publication, “High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia”, published this morning in Science Translational Medicine, continues to make headlines. Although you must be a registered user of GenomeWeb to view the article, you can find us featured here after making headlines earlier this morning in Xconomy.
Share page with colleagues
